Caplin Point Laboratories Profit & Loss Annual

Trade
BSE: 524742 | NSE: CAPLIPOINT | ISIN: INE475E01026 | Sector: Biotechnology & Drugs
1,969.55 +4.60 (0.23%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,694.101,466.731,269.411,061.29
Total Revenue 1,694.101,466.731,269.411,061.29
Costof Revenue Total 724.18694.80581.85491.47
Gross Profit 969.92771.93687.56569.82
Selling/ General/ Admin Expenses Total 143.59266.98233.31186.89
Depreciation/ Amortization 53.4444.9946.9036.97
Other Operating Expenses Total 274.89--0.00
Total Operating Expense 1,196.101,069.96921.33769.02
Operating Income 498.00396.77348.08292.27
Interest Inc( Exp) Net- Non- Op Total -5.10498.20345.40197.26
Other Net 66.945.123.082.23
Net Income Before Taxes 564.43451.35385.82313.62
Provisionfor Income Taxes 103.0174.3677.3762.19
Net Income After Taxes 461.42376.99308.45251.43
Minority Interest -4.33-0.73-8.61-9.16
Net Income Before Extra Items 457.09376.26299.84242.27
Net Income 457.09376.26299.84242.27
Total Adjustmentsto Net Income -0.10---
Income Availableto Com Excl Extra Ord 457.08376.26299.84242.27
Income Availableto Com Incl Extra Ord 457.08376.26299.84242.27
Diluted Net Income 457.08376.26299.84242.27
Diluted Weighted Average Shares 7.637.657.647.63
Diluted EPS Excluding Extra Ord Items 59.9049.1839.2631.74
DPS- Common Stock Primary Issue 2.504.504.003.00
Diluted Normalized EPS 59.9049.2239.2531.81
Research Development -631.90592.70536.95
Gain( Loss)on Saleof Assets --3.601.20-6.01
Unusual Expense( Income) --0.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts